Literature DB >> 22946777

Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis.

K Aanaes1, N Rasmussen, T Pressler, M Segelmark, H K Johansen, U Lindberg, N Høiby, M Carlsson, J Wieslander, C Buchwald.   

Abstract

Antineutrophil cytoplasm autoantibodies (ANCA) directed against bactericidal/permeability-increasing protein (BPI) are common in patients with cystic fibrosis (CF), and serum levels are correlated with lung colonization by Pseudomonas aeruginosa and the severity of lung damage. The production of BPI-ANCA may be due to the costimulation of BPI when mounting an immune response against P. aeruginosa. The effect of surgery aiming to eradicate bacteria and infected tissue on BPI-ANCA levels is sparsely described. A cohort of patients with CF were included: 53 patients having extensive image-guided sinus surgery (EIGSS) with topical postoperative antibiotic treatment, 131 non-operated controls and 36 who had double lung transplantation (LTX). In all 219 patients, serum samples before and after surgery or at similar intervals were analysed for IgG and IgA BPI-ANCA. The EIGSS group showed a highly significant decrease in both IgA and IgG BPI-ANCA levels compared with their own preoperative values and control group values (P < 0.001-0.02). The LTX patients also showed a highly significant decrease in both IgA and IgG BPI-ANCA levels (P < 0.001). EIGSS and LTX decrease IgA and IgG BPI-ANCA levels in patients with CF, indicating that extensive removal of infected tissue influences the pathogenic process of autoantibody production. The results shown herein are in favour of applying EIGSS in selected patients with CF and for using BPI-ANCA as a surrogate marker for guiding further therapeutic interventions.
© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946777     DOI: 10.1111/j.1365-3083.2012.02775.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.

Authors:  Kiranya E Tipirneni; Bradford A Woodworth
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-02-21

2.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18

3.  BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.

Authors:  Ulrika Lindberg; Malin Carlsson; Thomas Hellmark; Mårten Segelmark
Journal:  J Immunol Res       Date:  2015-07-26       Impact factor: 4.818

Review 4.  Vasculitis in Cystic Fibrosis.

Authors:  Francesca Sposito; Paul S McNamara; Christian M Hedrich
Journal:  Front Pediatr       Date:  2020-11-12       Impact factor: 3.418

5.  BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study.

Authors:  Ulrika Lindberg; Malin Carlsson; Claes-Göran Löfdahl; Mårten Segelmark
Journal:  Clin Dev Immunol       Date:  2012-12-30

6.  TAS2R38 is a novel modifier gene in patients with cystic fibrosis.

Authors:  Alice Castaldo; Gustavo Cernera; Paola Iacotucci; Chiara Cimbalo; Monica Gelzo; Marika Comegna; Antonella Miriam Di Lullo; Antonella Tosco; Vincenzo Carnovale; Valeria Raia; Felice Amato
Journal:  Sci Rep       Date:  2020-04-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.